Amgen near accord with hospital over drug royalty
Amgen Inc. said it has agreed to settle a dispute with Massachusetts General Hospital over royalties it pays the hospital for helping to invent Enbrel, Amgen's highly profitable drug to treat rheumatoid arthritis. (Full article: 353 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
